Picard Medical (PMI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Jul, 2026Executive summary
Annual Meeting scheduled for July 17, 2026, at 3:00 p.m. Mountain Time, to be held virtually.
Proxy materials and voting instructions are available online for shareholder review.
Stockholders are encouraged to vote using their provided control numbers and instructions.
Voting matters and shareholder proposals
Proxy materials detail the matters to be voted upon at the Annual Meeting.
Voting can be completed online prior to or during the virtual meeting.
Shareholder rights and capital structure
Stockholders receive unique control numbers for secure voting access.
Assistance is available for shareholders who have not received voting materials.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Picard Medical
- Proxy supplement corrects voting options and updates Audit Committee details for the 2026 meeting.PMI
Proxy filing - Key proposals include director elections, reverse stock split, and creation of high-vote Class B stock.PMI
Proxy filing - Proxy seeks approval for director elections, reverse split, new Class B stock, and auditor ratification.PMI
Proxy filing - Only FDA-approved total artificial heart maker, but faces ongoing losses and regulatory risks.PMI
Registration filing - Q1 2026 revenue jumped 85% to $1.2M, but losses and NYSE compliance risks persist.PMI
Q1 2026 - Sole FDA-approved TAH provider seeks $9.1M to fund next-gen heart tech and global expansion.PMI
Registration filing - IPO seeks $9.1M to fund artificial heart innovation amid ongoing losses and regulatory risks.PMI
Registration filing - Revenue up 12.5% to $4.94M, IPO raised $35.5M, cash improved, net loss $(27.0)M.PMI
Q4 2025 - Approval sought for major share increase and new issuances to enable financing and NYSE compliance.PMI
Proxy Filing